These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 10599479)

  • 1. The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders.
    Heim C; Nemeroff CB
    Biol Psychiatry; 1999 Dec; 46(11):1509-22. PubMed ID: 10599479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of corticotropin-releasing factor in the pathophysiology of affective and anxiety disorders: laboratory and clinical studies.
    Owens MJ; Nemeroff CB
    Ciba Found Symp; 1993; 172():296-308; discussion 308-16. PubMed ID: 8491091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies.
    Heim C; Nemeroff CB
    Biol Psychiatry; 2001 Jun; 49(12):1023-39. PubMed ID: 11430844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent changes in corticotropin-releasing factor systems due to early life stress: relationship to the pathophysiology of major depression and post-traumatic stress disorder.
    Heim C; Owens MJ; Plotsky PM; Nemeroff CB
    Psychopharmacol Bull; 1997; 33(2):185-92. PubMed ID: 9230630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent central nervous system effects of an adverse early environment: clinical and preclinical studies.
    Gutman DA; Nemeroff CB
    Physiol Behav; 2003 Aug; 79(3):471-8. PubMed ID: 12954441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders.
    Coplan JD; Andrews MW; Rosenblum LA; Owens MJ; Friedman S; Gorman JM; Nemeroff CB
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1619-23. PubMed ID: 8643680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of corticotropin-releasing factor in depression and anxiety disorders.
    Arborelius L; Owens MJ; Plotsky PM; Nemeroff CB
    J Endocrinol; 1999 Jan; 160(1):1-12. PubMed ID: 9854171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood.
    Heim C; Newport DJ; Heit S; Graham YP; Wilcox M; Bonsall R; Miller AH; Nemeroff CB
    JAMA; 2000 Aug; 284(5):592-7. PubMed ID: 10918705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific genetic manipulation of amygdala corticotropin-releasing factor reveals its imperative role in mediating behavioral response to challenge.
    Regev L; Tsoory M; Gil S; Chen A
    Biol Psychiatry; 2012 Feb; 71(4):317-26. PubMed ID: 21783178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of stress, corticotrophin releasing factor (CRF) and amygdala plasticity in chronic anxiety.
    Shekhar A; Truitt W; Rainnie D; Sajdyk T
    Stress; 2005 Dec; 8(4):209-19. PubMed ID: 16423710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing factor, norepinephrine, and stress.
    Koob GF
    Biol Psychiatry; 1999 Nov; 46(9):1167-80. PubMed ID: 10560023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRF system and mood disorders.
    Aubry JM
    J Chem Neuroanat; 2013 Dec; 54():20-4. PubMed ID: 24060608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurobiology of depression: inroads to treatment and new drug discovery.
    Nemeroff CB; Vale WW
    J Clin Psychiatry; 2005; 66 Suppl 7():5-13. PubMed ID: 16124836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early life influences on life-long patterns of behavior and health.
    McEwen BS
    Ment Retard Dev Disabil Res Rev; 2003; 9(3):149-54. PubMed ID: 12953293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticotrophin-releasing factor 1 activation in the central amygdale and visceral hyperalgesia.
    Taché Y
    Neurogastroenterol Motil; 2015 Jan; 27(1):1-6. PubMed ID: 25557223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Region-specific roles of the corticotropin-releasing factor-urocortin system in stress.
    Henckens MJ; Deussing JM; Chen A
    Nat Rev Neurosci; 2016 Oct; 17(10):636-51. PubMed ID: 27586075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse.
    Heim C; Newport DJ; Bonsall R; Miller AH; Nemeroff CB
    Am J Psychiatry; 2001 Apr; 158(4):575-81. PubMed ID: 11282691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anhedonia Following Early-Life Adversity Involves Aberrant Interaction of Reward and Anxiety Circuits and Is Reversed by Partial Silencing of Amygdala Corticotropin-Releasing Hormone Gene.
    Bolton JL; Molet J; Regev L; Chen Y; Rismanchi N; Haddad E; Yang DZ; Obenaus A; Baram TZ
    Biol Psychiatry; 2018 Jan; 83(2):137-147. PubMed ID: 29033027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early life adversity and serotonin transporter gene variation interact to affect DNA methylation of the corticotropin-releasing factor gene promoter region in the adult rat brain.
    van der Doelen RH; Arnoldussen IA; Ghareh H; van Och L; Homberg JR; Kozicz T
    Dev Psychopathol; 2015 Feb; 27(1):123-35. PubMed ID: 25640835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of neonatal stress on brain development: implications for psychopathology.
    Graham YP; Heim C; Goodman SH; Miller AH; Nemeroff CB
    Dev Psychopathol; 1999; 11(3):545-65. PubMed ID: 10532624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.